habener glp-1 Remembering Dr. Joel Reflections on the discovery GLP-1

Earlier studies have shown that GLP-1 agonists can reduce the pressure inside the skull, a squeeze thats been implicated in migraines

Redox-sensitive signaling factors and antioxidants: how tumor cells respond to ionizing radiation

Studies suggest that this IGFBP evasion results in a ~3-fold increase in potency in cell-based assays

Per a March 3, 2026 FDA press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products, including claims that implied sameness with FDA-approved medications

PMID: 8758120